UK markets open in 7 hours 23 minutes

Praxis Precision Medicines, Inc. (PRAX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
50.09-0.66 (-1.30%)
At close: 04:00PM EDT
50.09 0.00 (0.00%)
After hours: 04:18PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 868.22M
Enterprise value 789.42M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)136.76
Price/book (mrq)12.46
Enterprise value/revenue 322.61
Enterprise value/EBITDA -6.27

Trading information

Stock price history

Beta (5Y monthly) 2.88
52-week change 3216.20%
S&P500 52-week change 325.59%
52-week high 367.21
52-week low 312.45
50-day moving average 353.38
200-day moving average 331.35

Share statistics

Avg vol (3-month) 3214.52k
Avg vol (10-day) 3165.97k
Shares outstanding 517.11M
Implied shares outstanding 617.69M
Float 813.22M
% held by insiders 10.17%
% held by institutions 149.54%
Shares short (15 Apr 2024) 4763.93k
Short ratio (15 Apr 2024) 42.35
Short % of float (15 Apr 2024) 44.47%
Short % of shares outstanding (15 Apr 2024) 44.47%
Shares short (prior month 15 Mar 2024) 4409.35k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 329 Nov 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-5,593.40%

Management effectiveness

Return on assets (ttm)-77.79%
Return on equity (ttm)-169.13%

Income statement

Revenue (ttm)2.45M
Revenue per share (ttm)0.37
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -125.94M
Net income avi to common (ttm)-123.28M
Diluted EPS (ttm)-18.69
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)81.3M
Total cash per share (mrq)6.14
Total debt (mrq)2.5M
Total debt/equity (mrq)3.58%
Current ratio (mrq)5.39
Book value per share (mrq)7.92

Cash flow statement

Operating cash flow (ttm)-111.14M
Levered free cash flow (ttm)-65.69M